Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    19805654 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Conditions: Diabetes Mellitus Type 2;   Metabolic Syndrome;   Cardiovascular Disease;   Diastolic Dysfunction;   Fatty Liver
Intervention: Drug: Liraglutide
2 Completed Effect of Arginine Supplementation in the Metabolic Syndrome
Conditions: Overweight;   Hypertriglyceridemic Waist
Interventions: Dietary Supplement: One form of arginine;   Dietary Supplement: placebo
3 Completed Characterization of the Metabolic Fate of an Oral Arginine Form
Conditions: Overweight;   Hypertriglyceridemic Waist
Interventions: Dietary Supplement: A form Arginine;   Dietary Supplement: B form Arginine

Indicates status has not been verified in more than two years